Werner Rubas
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Drug Solubulity and Delivery Systems 12
- Advanced Drug Delivery Systems 10
- Oncology 13
- Drug Transport and Resistance Mechanisms 9
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Florence Delié (1 shared paper)George M. Grass (5 shared papers)Hans Peter Merkle (5 shared papers)Heidi Wunderli‐Allenspach (2 shared papers)Mary E. M. Cromwell (4 shared papers)Pascale Anderle (2 shared papers)Peter Langguth (2 shared papers)Constanze Hilgendorf (1 shared paper)
- Journals
- Pharmaceutical Research (6 papers)Journal of Pharmaceutical Sciences (4 papers)Journal of Microencapsulation (2 papers)Advanced Drug Delivery Reviews (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Werner Rubas
35 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 636
- Oncology 552
- Physiology 86
- Neurology 106
- Biomaterials 167
Countries citing papers authored by Werner Rubas
This map shows the geographic impact of Werner Rubas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Rubas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Rubas more than expected).
Fields of papers citing papers by Werner Rubas
This network shows the impact of papers produced by Werner Rubas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Rubas. The network helps show where Werner Rubas may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Rubas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 384 | |
| 2 | 2001 | 194 | |
| 3 | 1998 | 192 | |
| 4 | 1993 | 181 | |
| 5 | 2017 | 130 | |
| 6 | 1996 | 124 | |
| 7 | 2010 | 114 | |
| 8 | 1998 | 70 | |
| 9 | 1993 | 67 | |
| 10 | 2000 | 64 | |
| 11 | 1986 | 62 | |
| 12 | 1992 | 50 | |
| 13 | 2021 | 49 | |
| 14 | 2021 | 46 | |
| 15 | 2017 | 41 | |
| 16 | 1990 | 34 | |
| 17 | 1991 | 28 | |
| 18 | 1985 | 27 | |
| 19 | 2014 | 27 | |
| 20 | 2022 | 27 |
About Werner Rubas
Werner Rubas is a scholar working on Pharmaceutical Science, Oncology, Biomaterials, Immunology and Neurology, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (12 papers), Advanced Drug Delivery Systems (10 papers), Drug Transport and Resistance Mechanisms (9 papers), Nanoparticle-Based Drug Delivery (5 papers), Barrier Structure and Function Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Pharmaceutical Science (636 citations), Oncology (552 citations), Physiology (86 citations), Neurology (106 citations) and Biomaterials (167 citations). Werner Rubas has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Florence Delié, George M. Grass, Hans Peter Merkle, Heidi Wunderli‐Allenspach, Mary E. M. Cromwell, Pascale Anderle, Peter Langguth, Constanze Hilgendorf, Hilde Spahn-Langguth and Eva M. Niederer. Their work appears in journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences, Journal of Microencapsulation, Advanced Drug Delivery Reviews and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.